Basile Njei | Hepatology | Future Science Leader Award

Published on by World Top Scientists

Dr. Basile Njei | Hepatology | Future Science Leader Award

Co-Director, International Medicine Program, Yale University, United States

Dr. Basile Njei, an esteemed figure in Hepatology, has been honored with the Future Science Leader Award for his groundbreaking contributions to the field. Serving as the Co-Director of the International Medicine Program at Yale University in the United States, Dr. Njei embodies excellence in research and clinical practice. His dedication to advancing liver health through innovative approaches has earned him widespread recognition 🏅. With a commitment to education and global collaboration, Dr. Njei continues to inspire future generations of medical professionals while making significant strides in the fight against liver diseases.

Profile

Google Scholar

Education 🎓

Basile Njei received his Bachelor of Science in Biomedical Sciences from the University of Yaoundé 1, Cameroon in June 2005, followed by a Doctor of Medicine (M.D.) degree from the same institution in July 2008. He pursued further education at the University of Edinburgh, United Kingdom, earning a Master of Public Health (M.P.H.) in Epidemiology/Biostatistics in November 2009. Subsequently, he completed his residency in Internal Medicine at the University of Connecticut, Hartford, CT in June 2014. He then undertook fellowships in Gastroenterology/Hepatology and Clinical Research at Yale School of Medicine and Veterans Affairs, West Haven, CT, from June 2017 to June 2022. He capped his academic journey with a Ph.D. in Investigative Medicine from Yale University in December 2022.

Experience 👨‍🔬

Basile Njei has held various positions in academia and clinical practice. Currently, he serves as an Instructor in Digestive Diseases at Yale University, New Haven, CT, since 2023. Concurrently, he works as a Staff Gastroenterologist at Veterans Affairs, West Haven, CT, since 2023. His previous roles include Postdoctoral Research Fellow at Yale University and Veterans Affairs from 2021 to 2022, and Staff Gastroenterologist at UPMC-Western Maryland, Cumberland, MD, from 2018 to 2022.

Research Interests 🔬

Basile Njei’s research interests revolve around the clinical and genetic determinants of chronic liver diseases, with a focus on non-alcoholic fatty liver disease (NAFLD). He is particularly interested in leveraging artificial intelligence (AI) and epidemiologic techniques to study disease patterns, prognosis, and interventions in hepatology. His ongoing and recent projects encompass genome-wide association studies, AI models for disease prediction, and epidemiologic trends in liver cancer and COVID-19-related liver sequelae.

Awards 🏆

Basile Njei has garnered recognition for his contributions to research and clinical practice. He has received prestigious awards such as the Harvard Global Clinical Research Scholar (2022), University of Oxford Artificial Intelligence Scholar (2022), and Yale Center for Clinical Investigation Scholar (2021). Additionally, he has been honored with awards like the Samuel Kushlan Award for Excellence in Research (2017) and multiple science awards for research excellence during his academic journey.

Publications Top Notes 📚

“Artificial Intelligence in Medical Imaging for Cholangiocarcinoma Diagnosis” (2023), cited in J Gastroenterol Hepatol.

“Epidemiology, Diagnosis, and Treatments of Viral Hepatitis B, C and D” (2019), featured in Med Care.

“Interventions and Outcomes in Patients with Cirrhosis and NAFLD” (2019), published in Gastroenterology.

“Diagnosis of Malignant Biliary Strictures in Primary Sclerosing Cholangitis” (2017), highlighted in Gastrointest Endosc.

Wenyu Lin | Hepatology | Best Researcher Award

Published on by World Top Scientists

Dr. Wenyu Lin | Hepatology | Best Researcher Award

Doctor, Massachusetts General Hospital and Harvard Medical School, United States

🏆 Dr. Wenyu Lin, a distinguished figure in the field of Hepatology, has been honored with the prestigious Best Researcher Award. Serving at the renowned Massachusetts General Hospital and affiliated with Harvard Medical School in the United States, Dr. Lin’s contributions stand as pillars of excellence in the realm of liver health. With an unwavering commitment to advancing medical knowledge and patient care, Dr. Lin’s research endeavors have significantly enhanced our understanding of hepatic diseases and treatment modalities. His innovative approaches and groundbreaking discoveries have not only garnered accolades within the medical community but have also translated into tangible benefits for countless individuals affected by liver conditions. Dr. Lin’s dedication, expertise, and pioneering spirit exemplify the epitome of excellence in Hepatology research, setting a standard for future generations to aspire to. 🌟

Profile

Orcid

Education

🎓 Dr. Wenyu Lin’s academic journey is marked by a relentless pursuit of knowledge and expertise in the realm of biology and medicine. Beginning with a Bachelor of Science in Biology from East China Normal University, Shanghai, China, from 1980 to 1984, Dr. Lin laid the groundwork for his future pursuits. His passion for understanding the intricacies of life led him to pursue a Master of Science in Zoology at the same institution from 1984 to 1987, deepening his understanding of organismal biology. Driven by an insatiable curiosity, he embarked on a transformative Ph.D. journey in Molecular, Cellular, and Organismal Biology at the University of Massachusetts from 1996 to 2003, where he honed his research skills and contributed to the scientific community’s understanding of cellular mechanisms. Following the completion of his doctoral studies, Dr. Lin further enriched his expertise through a prestigious postdoctoral fellowship at Harvard Medical School and Massachusetts General Hospital (MGH) from 2003 to 2005, delving into cutting-edge research at the intersection of academia and clinical practice. Dr. Lin’s academic trajectory underscores his unwavering dedication to advancing scientific knowledge and his commitment to excellence in every facet of his career. 🌱

Professional Experience

🔬 Dr. Wenyu Lin’s professional journey is a testament to his unwavering dedication to scientific inquiry and academic excellence. Following his academic pursuits, Dr. Lin embarked on a career in academia, serving as a respected University Faculty member at Xiamen University, Fujian, P.R. of China, from July 1987 to December 1989. His commitment to global collaboration and cross-cultural exchange led him to further his expertise as a Visiting Scholar at the University of San Francisco in San Francisco, CA, from December 1989 to January 1991. Dr. Lin’s thirst for knowledge and research opportunities propelled him to assume the role of a Research Fellow at the University of Rhode Island in Kingston, RI, from January 1991 to January 1993, where he made significant contributions to the field of biological sciences. His trajectory then led him to the prestigious Harvard Medical School’s New England Regional Primate Research Center in Southborough, MA, where he served as a Research Assistant from February 1993 to May 1994, further honing his skills in medical research. Dr. Lin’s dedication and expertise were further underscored during his tenure as a Research Associate at Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, from May 1994 to September 2000, where he played an integral role in advancing scientific knowledge in the medical field. Currently, Dr. Lin continues to inspire and educate future generations as an Instructor in Medicine at Harvard Medical School and Massachusetts General Hospital since October 2005, where his passion for teaching and research continues to shape the next era of medical innovation. 🌟

Academic Background

🔬 With over 25 years of dedicated research experience, I have established a robust track record of accomplishments in the fields of immunology, molecular biology, and virology, focusing particularly on HIV, HCV, and HBV-related liver diseases. My research endeavors have spanned fundamental investigations to translational studies, aimed at unraveling the intricate mechanisms underlying these complex viral infections. Within the realm of HCV, HBV, and HIV, my contributions have been multifaceted. Firstly, I have delved into elucidating the intricate viral-host interactions of HCV, shedding light on the mechanisms driving infection and pathogenesis. Additionally, my work has advanced pathogenetic studies in coinfections such as HCV-HIV and HBV-HIV, along with investigating the implications of HIV on liver disease progression. One notable area of focus has been the identification of key regulators governing the replication processes of HCV and HBV.

Publications Top Notes

  1. Publication Title: “HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway”
    • Year: 2024
    • Authors: Xu M, Warner C, Duan X, Cheng Z, Jeyarajan AJ, Li W, Wang Y, Shao T, Salloum S, Chen PJ, Yu X, Chung RT*, Lin W*.
    • Journal: J Hepatol.
    • PMID: 38311121
    • DOI: 10.1016/j.jhep.2024.01.026
  2. Publication Title: “Hsa_circ_0007321 regulates Zika virus replication through miR-492/NFKBID/NF-κB signaling pathway”
    • Year: 2023
    • Authors: Kang L, Xie H, Ye H, Jeyarajan AJ, Warner CA, Huang Y, Shi Y, Li Y, Yang C, Xu M, Lin W, Sun J, Chen L, Duan X, Li S.
    • Journal: J Virol.
    • PMID: 38051045
    • DOI: 10.1128/jvi.01232-23
  3. Publication Title: “Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China”
    • Year: 2023
    • Authors: Li S, Duan X*, Jiang N, Jeyarajan AJ, Warner CA, Li Y, Xu M, Li X, Tan L, Li M, Shao T, Li S, Chen L, Gao Y*, Han M*, Lin W*.
    • Journal: Int Immunopharmacol.
    • PMID: 37201409
    • DOI: 10.1016/j.intimp.2023.110333
  4. Publication Title: “LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients”
    • Year: 2022
    • Authors: Altinbas A, Holmes JA, Salloum S, Lidofsky A, Alatrakchi N, Somsouk M, Hunt P, Deeks S, Chew KW, Lauer G, Kruger A, Lin W, Chung RT.
    • Journal: Biomark Med.
    • Year: 2022
    • PMID: None provided
    • DOI: 10.2217/bmm-2021-0596
  5. Publication Title: “Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway”
    • Year: 2022
    • Authors: Li W, Duan X, Zhu C, Liu X, Jeyarajan AJ, Xu M, Tu Z, Sheng Q, Chen D, Zhu C, Shao T, Cheng Z, Salloum S, Schaefer EA, Kruger AJ, Holmes JA, Chung RT*, Lin W*.
    • Journal: J Immunol.
    • PMID: 35022275
    • DOI: 10.4049/jimmunol.2001453
  6. Publication Title: “[18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models”
    • Year: 2022
    • Authors: Shao T, Chen Z, Rong J, Belov V, Chen J, Jeyarajan A, Deng X, Fu H, Yu Q, Rwema SH, Lin W, Papisov M, Josephson L, Chung RT, Liang SH.
    • Journal: Acta Pharm Sin B.
    • PMID: 35127387
    • DOI: 10.1016/j.apsb.2021.07.007
  7. Publication Title: “Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal Hemorrhage”
    • Year: 2021
    • Authors: Li S, Huang P, Jeyarajan AJ, Ma C, Zhu K, Zhu C, Jiang N, Li M, Shao T, Han M*, Tan L*, Lin W*.
    • Journal: Front Med (Lausanne).
    • PMID: 34926512
    • DOI: 10.3389/fmed.2021.770836
  8. Publication Title: “The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis”
    • Year: 2021
    • Authors: Huang P, Wang Y, Yue M, Ge Z, Xia X, Jeyarajan AJ, Holmes JA, Yu R, Zhu C, Yang S, Lin W*, Chung RT*.
    • Journal: Liver Int.
    • PMID: 34051040
    • DOI: 10.1111/liv.14976
  9. Publication Title: “Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase”
    • Year: 2021
    • Authors: Salloum S, Jeyarajan AJ, Kruger AJ, Holmes JA, Shao T, Sojoodi M, Kim MH, Zhuo Z, Shroff SG, Kassa A, Corey KE, Khan SK, Lin W, Alatrakchi N, Schaefer EAK, Chung RT.
    • Journal: Cell Mol Gastroenterol Hepatol.
    • PMID: 34118488
    • DOI: 10.1016/j.jcmgh.2021.06.003
  10. Publication Title: “Differentially expressed immune response genes in COVID-19 patients based on disease severity”
  • Year: 2021
  • Authors: Li S, Duan X, Li Y, Li M, Gao Y, Li T, Li S, Tan L, Shao T, Jeyarajan AJ, Chen L, Han M*, Lin W*, Li X*.
  • Journal: Aging (Albany NY).
  • PMID: 33780352
  • DOI: 10.18632/aging.20287